Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 VaccineGlobeNewsWire • 05/04/20
Catalent, Inc (CTLT) CEO John Chiminski on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/03/20
BridgeBio Pharma’s Gene Therapy Subsidiaries Enter Strategic Partnership with Catalent for Dedicated Gene Therapy Development and Manufacturing CapacityGlobeNewsWire • 01/10/20
Catalent, Inc (CTLT) CEO John Chiminski on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/06/19
Catalent, Inc. (CTLT) CEO John Chiminski on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/27/19